CLINICAL_TRIALS
trial_result
· 2008-10-16
Clinical Trial Update: Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]
Summary
A Phase 2 study of SU011248 for metastatic non-small cell lung cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED